CompanyGraph
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 5
- ScaleMarket cap is $12.28B, above the global median of $1.14B
- FinancialsHigh earnings quality
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
12.28BUSDvs all stocks (USD)
Revenue (TTM)
599.96MUSDvs all stocks (USD)
Profit Margin
-7.35%Beta
1.24xvs all stocks
52-Week Change
98.37%vs all stocks
Forward Annual Dividend Yield
0.00%vs all stocks
Market Capitalization
12.28BUSDvs all stocks (USD)
Enterprise Value
11.60BUSDvs all stocks (USD)
Forward P/E
87.85xPrice to Sales (TTM)
20.68xPrice to Book (MRQ)
12.89xEnterprise to Revenue
19.33xGross Margin
77.93%Profit Margin
-7.35%Operating Margin
-7.12%Return on Assets (TTM)
-2.92%Return on Equity (TTM)
-4.93%Revenue (TTM)
599.96MUSDvs all stocks (USD)
Revenue per Share (TTM)
5.02USDUpdated Oct 27, 2026Quarterly Revenue Growth
28.70%Gross Profit (TTM)
467.14MUSDvs all stocks (USD)
EBITDA (TTM)
-40.56MUSDvs all stocks (USD)
Net Income (TTM)
-44.07MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
28.73%Operating Cash Flow (TTM)
176.26MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
202.77MUSDvs all stocks (USD)
Forward Annual Dividend Yield
0.00%vs all stocks
Trailing Annual Dividend Rate
0.00USDUpdated Oct 27, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Revenue
531.84MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
123.45MUSDFY2025 · Dec 31, 2025Gross Profit
408.39MUSDFY2025 · Dec 31, 2025Operating Income
-89.93MUSDvs all stocks (USD)
Pre-tax Income
-66.04MUSDFY2025 · Dec 31, 2025Income Tax Expense
5.78MUSDFY2025 · Dec 31, 2025Net Income
-71.82MUSDFY2025 · Dec 31, 2025EBIT
-89.93MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-63.50MUSDFY2025 · Dec 31, 2025Research & Development
195.09MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
300.42MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
25.82MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.6200USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.6200USDFY2025 · Dec 31, 2025Basic Shares Outstanding
116.20MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
116.20MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-71.82MUSDFY2025 · Dec 31, 2025Operating Cash Flow
136.50MUSDFY2025 · Dec 31, 2025Free Cash Flow
133.04MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
76.55MUSDFY2025 · Dec 31, 2025Income Tax Paid
7.94MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-71.82MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
24.50MUSDFY2025 · Dec 31, 2025Stock-based Compensation
156.66MUSDFY2025 · Dec 31, 2025Other Non-cash Items
8.97MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-29.33MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
3.62MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
43.90MUSDFY2025 · Dec 31, 2025Capital Expenditures
-3.46MUSDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Purchase of Investments
-625.87MUSDFY2025 · Dec 31, 2025Sale of Investments
477.06MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-152.27MUSDFY2025 · Dec 31, 2025Other Financing Charges
7.24MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
7.24MUSDFY2025 · Dec 31, 2025Shares Outstanding
123.05MSharesUpdated Oct 27, 2026Float Shares
110.51MSharesUpdated Oct 27, 2026Shares Short
6.49MSharesUpdated Oct 27, 2026Short Ratio
3.60daysvs all stocks
Short % of Shares Outstanding
5.95%vs all stocks
% Held by Insiders
9.89%vs all stocks
% Held by Institutions
95.28%vs all stocks
Total Cash (MRQ)
824.49MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
6.69USDUpdated Oct 27, 2026Total Debt (MRQ)
14.57MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0152xCurrent Ratio (MRQ)
2.13xBook Value per Share (MRQ)
7.81USDUpdated Oct 27, 2026Total Assets
1.34BUSDvs all stocks (USD)
Total Current Assets
873.01MUSDFY2025 · Dec 31, 2025Total Liabilities
453.93MUSDFY2025 · Dec 31, 2025Total Non-current Assets
468.37MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
46.41MUSDFY2025 · Dec 31, 2025Total Current Liabilities
407.52MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
75.84MUSDFY2025 · Dec 31, 2025Other Short-term Investments
628.57MUSDFY2025 · Dec 31, 2025Accounts Receivable
119.95MUSDFY2025 · Dec 31, 2025Accounts Payable
14.17MUSDFY2025 · Dec 31, 2025Short-term Debt
5.78MUSDFY2025 · Dec 31, 2025Deferred Revenue
309.60MUSDFY2025 · Dec 31, 2025Long-term Debt
6.68MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
7.33MUSDFY2025 · Dec 31, 2025Common Stock (Book)
335.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-431.49MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
887.45MUSDvs all stocks (USD)
52-Week Low
34.05USDUpdated Oct 27, 202652-Week High
105.76USDUpdated Oct 27, 202652-Week Change
98.37%vs all stocks
Beta
1.24xvs all stocks
50-Day MA
93.48USDUpdated Oct 27, 2026200-Day MA
70.77USDUpdated Oct 27, 2026Avg 10-Day Volume
2.12MSharesUpdated Oct 27, 2026Avg 30-Day Volume
1.71MSharesUpdated Oct 27, 2026Diluted EPS (TTM)
-0.3700USDUpdated Oct 27, 2026Other Income / Expense
-1.93MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Diagnostic
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.78Profit Margin: -0.07
Financial Health
High earnings qualityNotable
Earnings Quality Score: 0.87
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Market cap is $12.28B, above the global median of $1.14BNotable
Market cap (USD): 12,282,043,588Global Median: 1,138,450,684.034
Revenue is $599.96M, above the global median of $562.3MNotable
Revenue (USD): 599,961,984Global Median: 562,304,852.367
Levered free cash flow is $202.77M, above the global median of $18.69MNotable
Levered free cash flow (USD): 202,769,120Global Median: 18,689,872.41
Companies that share the same coordination system — how they create, deliver, or capture value.
Paycom Software, Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
BrightSpring Health Services, Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
DigitalOcean Holdings Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Akamai Technologies Inc.
Tier 1FlowRecurring-Revenue Lock-InProductionInterface
One 97 Communications Ltd.
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
Chime Financial, Inc. – Class A Common Stock
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
Netskope, Inc.
Tier 1FlowRecurring-Revenue Lock-InRuleProduction
DocuSign Inc.
Tier 1FlowRecurring-Revenue Lock-InProductionInterface
Paylocity Holding Corporation
Tier 1FlowRecurring-Revenue Lock-InProductionInterface
HealthEquity Inc.
Tier 1FlowRecurring-Revenue Lock-InRiskInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Taysha Gene Therapies Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Travere Therapeutics Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Foresee Pharmaceuticals Co., Ltd.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC